-
Product Insights
NewMicrotubule Associated Protein Tau – Drugs In Development, 2024
The Microtubule Associated Protein Tau pipeline drugs market research report outlays comprehensive information on the Microtubule Associated Protein Tau targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Cardiovascular, and Genetic Disorders which include indications of Alzheimer's Disease, Tauopathies, Type 2 Diabetes, Amyloidosis, Myocardial Infarction, Ischemia, and Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome). It...
-
Product Insights
NewSynaptosomal Associated Protein 25 – Drugs In Development, 2024
The Synaptosomal Associated Protein 25 pipeline drugs market research report outlays comprehensive information on the Synaptosomal Associated Protein 25 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Musculoskeletal Disorders, Dermatology, and Ophthalmology which include indications of Upper Limb Muscle Spasticity, Spasmodic Torticollis (Cervical Dystonia), Unspecified Musculoskeletal Disorders, Hemifacial Spasm, Axillary Hyperhidrosis, Sudoriferous (Sweat) Gland...
-
Product Insights
NewMelanoma Associated Antigen 3 – Drugs In Development, 2024
The Melanoma Associated Antigen 3 pipeline drugs market research report outlays comprehensive information on the Melanoma Associated Antigen 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Non-Small Cell Lung Cancer, and Melanoma. It also reviews key players involved in Melanoma Associated Antigen 3 targeted therapeutics development with respective active and dormant...
-
Product Insights
NewRho Associated Protein Kinase 2 – Drugs In Development, 2024
The Rho Associated Protein Kinase 2 pipeline drugs market research report outlays comprehensive information on the Rho Associated Protein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Gastrointestinal, Oncology, and Central Nervous System which include indications of Idiopathic Pulmonary Fibrosis, Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease), Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Pancreatic...
-
Product Insights
NewRho Associated Protein Kinase 1 – Drugs In Development, 2024
The Rho Associated Protein Kinase 1 pipeline drugs market research report outlays comprehensive information on the Rho Associated Protein Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Non Malignant Disorders, and Gastrointestinal which include indications of Oncology, Breast Cancer, Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous...
-
Product Insights
NewInterleukin 1 Receptor Associated Kinase – Drugs In Development, 2024
The Interleukin 1 Receptor Associated Kinase pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Receptor Associated Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Dermatology, and Gastrointestinal which include indications of Inflammation, Rheumatoid Arthritis, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Myelodysplastic Syndrome, Atopic Dermatitis (Atopic Eczema), Diabetic Foot Ulcers,...
-
Product Insights
NewMembrane Associated Progesterone Receptor Component 1 – Drugs In Development, 2024
The Membrane Associated Progesterone Receptor Component 1 pipeline drugs market research report outlays comprehensive information on the Membrane Associated Progesterone Receptor Component 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, and Ophthalmology which include indications of Alzheimer's Disease, Parkinson's Disease, Hepatocellular Carcinoma, Solid Tumor, Dry (Atrophic) Macular Degeneration, and Geographic Atrophy. It...
-
Product Insights
NewInterleukin 1 Receptor Associated Kinase 4 – Drugs In Development, 2024
The Interleukin 1 Receptor Associated Kinase 4 pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Receptor Associated Kinase 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Dermatology, and Undisclosed which include indications of Inflammation, Rheumatoid Arthritis, Myelodysplastic Syndrome, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Atopic Dermatitis (Atopic Eczema), Hidradenitis...
-
Product Insights
NewKelch Like ECH Associated Protein 1 – Drugs In Development, 2024
The Kelch Like ECH Associated Protein 1 pipeline drugs market research report outlays comprehensive information on the Kelch Like ECH Associated Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Genito Urinary System, and Gastrointestinal which include indications of Amyotrophic Lateral Sclerosis, Parkinson's Disease, Solid Tumor, Glioblastoma Multiforme (GBM), Chronic Kidney Disease...
-
Product Insights
NewInterleukin 1 Receptor Associated Kinase 1 – Drugs In Development, 2024
The Interleukin 1 Receptor Associated Kinase 1 pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Receptor Associated Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Gastrointestinal which include indications of Myelodysplastic Syndrome, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Psoriasis, Rheumatoid Arthritis, Diabetic Foot Ulcers, Ulcerative Colitis,...